On the other side, GPR32, another RvD receptor, proved to be a worse prognosis index in other cancers such as kidney chromophobe (KICH), cervical kidney renal papillary cell carcinoma (KIRP) and in low grade glioma (TCGA-LGG). Here, GPR32 is linked to glioma.